ICD-10-CM Billable Code

L49.0

Exfoliation due to erythematous condition involving less than 10 percent of body surface

Clinical Classification Guidelines

Inclusion Terms

  • Exfoliation due to erythematous condition NOS

Medical Intelligence & Overview

ICD-10 Code L49.0 refers to a skin condition characterized by the shedding or peeling of the outer skin layer caused by an erythematous (red or inflamed) skin reaction. This particular diagnosis involves less than 10 percent of the body surface. It is known as exfoliation following erythematous conditions, with the exact cause sometimes unspecified. Recognized as 'Exfoliation due to erythematous condition NOS,' this condition can affect individuals of all ages and may vary in severity and duration.

Causes & Symptoms

Clinical Causes: Skin reactions to medications, such as antibiotics or other drugs Infections that cause skin inflammation, including viral, bacterial, or fungal infections Allergic reactions to topical or systemic substances Dermatologic conditions like eczema or dermatitis that lead to redness and peeling Exposure to environmental factors such as extreme temperatures or chemicals Underlying systemic illnesses that manifest with skin symptoms Less commonly, autoimmune disorders affecting the skin

Key Symptoms: Redness and inflammation of the skin (erythema) Localized or widespread peeling or exfoliation of the skin Itching or discomfort in affected areas Dry, flaky skin that may crack or bleed in severe cases Possible presence of blisters or erosions in affected regions Mild to moderate pain or sensitivity in areas of skin peeling

Diagnostic & Treatment

Diagnosis Path: Diagnosis primarily involves a physical examination of the skin by a healthcare professional. The dermatologist assesses the extent and pattern of erythema and exfoliation. Additional investigations might include skin biopsies, blood tests, or allergy testing to determine underlying causes or rule out other skin conditions. Because the condition involves less than 10% of body surface, it typically presents as localized or mild widespread areas, aiding in clinical identification.

Treatment Protocols: Treatment strategies focus on relieving symptoms and addressing underlying causes. These may include topical corticosteroids to reduce inflammation, moisturizers to hydrate the skin, and antihistamines for itching relief. In cases where an infection or medication reaction is suspected, stopping the offending agent or prescribing appropriate antimicrobial therapy could be necessary. Supportive care with gentle skin cleansing and avoiding irritants helps promote healing. The course and prognosis depend on the underlying cause and severity of the skin reaction.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is L49.0 a billable ICD-10 code?
Yes, L49.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report L49.0?
Clinical documentation must specify the nature of Exfoliation due to erythematous condition involving less than 10 percent of body surface and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

erythematous percent exfoliation condition surface